TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have updated their coverage […]
Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have updated their coverage […]
